Updated June 2026. Comprehensive guide to buying prescription weight loss injections online across the European Union, EEA, and UK. Includes country-by-country availability, complete product comparison, eligibility criteria, regulatory context, and step-by-step ordering process.

Weight loss injections have transformed obesity treatment in Europe between 2021 and 2026. What was once a market dominated by a single daily injection (Saxenda, approved 2015) now offers seven major prescription options across multiple price points and delivery schedules. With over 60 million European adults clinically classified as obese according to WHO European data, demand has driven extraordinary innovation — and unfortunately, an equally dramatic rise in counterfeit medications and unregulated online sellers.

This complete 2026 guide explains exactly how to buy weight loss injections online safely and legally across Europe, what’s available in your specific country, how to determine which medication suits your medical profile, and what to expect from the entire process — from initial consultation through delivery and ongoing treatment.

What Are Weight Loss Injections in 2026?

Weight loss injections in 2026 fall into two main pharmacological classes, all using self-administered subcutaneous injection pens designed for safe use at home without medical supervision:

GLP-1 Receptor Agonists (Single-Hormone)

These medications mimic glucagon-like peptide 1 (GLP-1), a natural gut hormone released after eating. By extending the body’s natural fullness response, they reduce appetite, slow gastric emptying, and improve insulin sensitivity. Current options include semaglutide (sold as Wegovy for weight loss and Ozempic for diabetes) and liraglutide (sold as Saxenda, Biolide, Nevolat, and Plaobes).

Dual GLP-1/GIP Agonists (Newest Generation)

The first dual-action weight loss medication, tirzepatide (sold as Mounjaro), targets both GLP-1 and GIP (glucose-dependent insulinotropic polypeptide) simultaneously. This dual hormone approach produces the highest average weight loss of any treatment ever approved for the European market — up to 22.5% of body weight in pivotal clinical trials published in The New England Journal of Medicine.

Why Weight Loss Injections Have Replaced Older Methods

Until 2018, prescription weight loss across Europe meant Orlistat (Xenical) capsules or appetite suppressants with substantial side effect profiles — and average weight loss of just 5–10% over a year. The introduction of GLP-1 receptor agonists fundamentally changed the calculus. Average weight loss tripled. Cardiovascular outcomes improved. Quality of life scores rose dramatically. Diabetes remission became achievable for many patients.

Most importantly, these injections work in a way that aligns with how the body naturally regulates hunger. Patients consistently report that food simply becomes less interesting — without the harsh stimulant effects of older appetite suppressants or the social inconvenience of orlistat’s gastrointestinal effects. This neuroendocrine alignment is why GLP-1 medications have achieved sustained mass adoption in a way previous weight loss drugs never did.

Complete Comparison: 7 Weight Loss Injections Available in Europe 2026

Here’s how the seven major prescription weight loss injections compare across the European market in mid-2026:

1. Mounjaro (Tirzepatide) — The Strongest Option for Severe Obesity

Mounjaro stands alone in the European market as the only dual GLP-1/GIP receptor agonist currently approved for chronic weight management. In the SURMOUNT-1 clinical trial, patients on the maximum 15 mg weekly dose lost an average of 22.5% of starting body weight over 72 weeks — meaning a person starting at 100 kg lost roughly 22.5 kg.

The dual-hormone mechanism produces superior outcomes because GIP and GLP-1 work synergistically. GIP enhances insulin sensitivity in adipose tissue, while GLP-1 dominates appetite regulation. Together, they produce stronger weight loss than either pathway alone — explaining why Mounjaro outperforms semaglutide-based Wegovy in head-to-head comparisons.

Mounjaro suits patients seeking maximum weight loss, those with severe obesity (BMI ≥ 40), patients who haven’t achieved their goals on semaglutide, and patients with type 2 diabetes (where Mounjaro is also licensed for glycemic control). The trade-off is cost — at €148.00 starting, Mounjaro is the most expensive injection option, though still all-inclusive of consultation, dispensing, and delivery.

2. Wegovy (Semaglutide) — The Best-Known Choice With Cardiovascular Benefits

Wegovy is the most widely-prescribed weight loss injection in Europe and the most-researched. Beyond its weight loss effects (21% average reduction over 68 weeks), the SELECT cardiovascular outcomes trial demonstrated a 20% reduction in major cardiovascular events for patients with established heart disease — making Wegovy the first weight loss medication ever proven to extend life expectancy.

For patients with cardiovascular risk factors (heart disease, history of stroke, peripheral artery disease), Wegovy offers benefits beyond weight loss that no other current treatment matches. It’s also better-established for long-term use, with safety data extending over a decade since semaglutide was first approved in any form.

Starting at €99.00, Wegovy is significantly more affordable than Mounjaro while still providing exceptional weight loss outcomes. For most patients, it represents the best risk-benefit profile available in 2026.

3. Saxenda, Biolide, Nevolat, Plaobes — The Liraglutide Family

Four daily injections share the same active ingredient — liraglutide — at the same 3.0 mg maintenance dose. All produce 8–12% average weight loss over 56 weeks. The differences are pricing, branding, and country availability:

• Saxenda — the original brand (Novo Nordisk), the only liraglutide product also licensed for adolescents 12–17. Starting at €375.00.
• Nevolat — MHRA-approved, particularly strong in the UK market. The most affordable liraglutide option at €53.99 starting.
• Biolide — competitive mid-range pricing (€110.99) with broad EU distribution.
• Plaobes — specifically distributed across UK, Germany, Netherlands, Norway, Poland, and Spain. €125.00 starting.

Daily liraglutide injections suit patients who prefer daily routines (some find this easier to remember than weekly), patients with moderate obesity goals, those who don’t need the full weight loss potential of weekly GLP-1s, and patients seeking lower-cost GLP-1 options.

4. Ozempic (Semaglutide for Diabetes)

Ozempic contains the same active ingredient as Wegovy (semaglutide) but is licensed specifically for type 2 diabetes management, with doses up to 2.0 mg weekly (compared to Wegovy’s 2.4 mg). For diabetic patients, Ozempic reduces HbA1c by 1.5–1.8 percentage points and produces secondary weight loss of 4–6 kg in the first year.

Ozempic is the appropriate option for patients with type 2 diabetes who need glycemic control. For non-diabetic patients seeking weight loss, Wegovy is the medically appropriate choice. Off-label Ozempic use for weight loss in non-diabetic patients has caused EU-wide supply shortages affecting diabetic patients who medically depend on it — we discourage this practice.

Country-by-Country Availability: Where to Buy Weight Loss Injections in Europe

EU Slim Store ships weight loss injections to most European Union, EEA, and UK markets. Each country has slightly different regulatory frameworks, delivery times, and patient preferences:

🇳🇱 Netherlands — Afslankinjecties Online Kopen

The Netherlands is one of the most established markets for online weight loss treatment. Dutch residents can access all 7 major injection options through our service, with prescriptions issued by BIG-registered Dutch doctors and dispensed from IGJ-registered pharmacies. Delivery via PostNL typically arrives within 2–3 working days in plain, unbranded packaging.

Dutch basisverzekering (basic health insurance) covers Mounjaro and Ozempic for confirmed type 2 diabetes but does not cover weight management indications. Most Dutch patients pay privately for weight loss treatment. The Dutch online telehealth market is one of the most mature in Europe, with patients reporting high satisfaction with the convenience of remote consultation versus traditional GP appointments.

🇩🇪 Germany — Abnehmspritzen Online Kaufen

Germany has the largest weight loss medication market in Europe by population, with extraordinary search volume for terms like “Abnehmspritze kaufen” and “Wegovy bestellen Deutschland.” German patients can access Mounjaro, Wegovy, Saxenda, Ozempic, Biolide, Nevolat, and Plaobes following online consultation. Delivery takes 3–5 working days via Deutsche Post DHL.

Since 2024, German regulators (BfArM, Bundesinstitut für Arzneimittel und Medizinprodukte) have implemented stricter requirements for online GLP-1 prescribing. Our consultation process is fully compliant with these standards — every prescription receives genuine physician review rather than algorithmic auto-approval.

🇬🇧 United Kingdom — Buy Weight Loss Injections Online UK

The UK weight loss injection market grew enormously between 2023 and 2026 as NHS waiting lists for weight management services stretched to 18+ months in some regions. UK patients turning to private telehealth can access Wegovy (the most-prescribed option in the UK), Mounjaro, Saxenda, and Nevolat (specifically MHRA-approved) through our GPhC-registered partner pharmacy (registration 1230976). Delivery via Royal Mail Tracked 24 in 1–2 working days.

The MHRA (Medicines and Healthcare products Regulatory Agency) strictly regulates online prescription medications. Always verify that any online pharmacy claiming UK authorisation displays a valid GPhC registration number and appears in the official GPhC registers.

🇵🇱 Poland — Kupić Zastrzyki na Odchudzanie Online

Poland represents a fast-growing market for weight loss injections with relatively less competition than Western European markets. Polish patients can order Wegovy, Mounjaro, Plaobes, and others following online consultation with a European-licensed physician. Delivery to Poland takes 4–5 working days.

🇧🇪 Belgium — Acheter Injection Perte de Poids en Ligne

Belgian patients (both French-speaking Walloon and Dutch-speaking Flemish regions) can complete consultations in their preferred language and receive any of our 7 injection options. Delivery via Bpost in 2–4 working days. Belgium’s central European location means delivery is reliably quick.

🇫🇷 France — Injection Perte de Poids en Ligne

France has historically taken a conservative approach to online prescription medications, with ANSM (Agence nationale de sécurité du médicament) implementing rigorous standards. Our French-language consultation process meets current ANSM requirements. French patients can access Wegovy, Saxenda, and other major treatments with delivery via La Poste in 3–5 working days.

🇳🇴 Norway — Kjøpe Vekttap Injeksjon På Nett

Norwegian patients (within the EEA) can order weight loss injections following consultation that respects Statens Legemiddelverk standards. Norway has historically had restrictive policies on online weight loss prescribing — our service meets the current authoritative requirements. Delivery via Posten Norge in 4–6 working days.

Eligibility Criteria: Who Qualifies for Weight Loss Injections in 2026?

Eligibility for prescription weight loss injections follows European Medicines Agency clinical guidance. The standard criteria are:

• BMI ≥ 30 (clinical obesity), OR
• BMI ≥ 27 combined with at least one weight-related health condition

Qualifying weight-related conditions include:

• Type 2 diabetes or prediabetes
• Hypertension (high blood pressure)
• Dyslipidaemia (abnormal cholesterol/triglycerides)
• Obstructive sleep apnoea
• Established cardiovascular disease
• Polycystic ovary syndrome (PCOS) with insulin resistance
• Non-alcoholic fatty liver disease (NAFLD/MASLD)
• Osteoarthritis with significant weight-related impact

Check your BMI with our free BMI calculator to determine your starting point.

Contraindications — Who Cannot Take Weight Loss Injections

Weight loss injections are not appropriate for everyone. Absolute contraindications include:

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple endocrine neoplasia syndrome type 2 (MEN 2)
• Severe gastrointestinal disease (gastroparesis, severe GERD, history of intestinal obstruction)
• Active pancreatitis or history of recurrent pancreatitis
• Pregnancy or active breastfeeding
• Patients planning pregnancy within 2 months (Mounjaro) or 2 months (Wegovy)
• Type 1 diabetes (these medications don’t substitute for insulin)
• Diabetic ketoacidosis
• Known severe allergic reaction to any GLP-1 agonist

Relative contraindications requiring careful medical assessment include moderate-to-severe diabetic retinopathy, severe gastroparesis, history of bariatric surgery, and chronic kidney disease (especially CKD stages 4–5).

How to Buy Weight Loss Injections Online — The 2026 Process

The legitimate online process for buying weight loss injections in Europe has six clear steps:

Step 1: Determine Your Eligibility

Before starting any consultation, use our BMI calculator to confirm your BMI is at least 27 (with comorbidities) or 30 (without). If your BMI is below the threshold, weight loss injections aren’t medically appropriate — your reviewing doctor would not be able to prescribe them safely or legally.

Step 2: Choose Your Preferred Treatment (or Let the Doctor Recommend)

Browse our complete range of weight loss injections to understand your options. You don’t need to make a final decision before consultation — many patients prefer to let the doctor recommend based on their full medical profile. If you have a preference (e.g., wanting Mounjaro for maximum weight loss, or Wegovy for cardiovascular benefits), note this in the consultation.

Step 3: Complete the Free Online Consultation

Our 15-minute online consultation collects all the information a licensed doctor needs to assess your eligibility safely. Questions cover:

• Personal demographics (age, sex, location)
• Current BMI and weight history
• Existing medical conditions
• Current medications (critical for drug interaction screening)
• Personal and family medical history (especially thyroid cancer, pancreatitis, eating disorders)
• Previous weight loss treatment history
• Goals and treatment preferences

Be completely honest in your responses. Inaccurate information could result in serious medical complications — and your doctor cannot know what you don’t tell them.

Step 4: Doctor Review (Within 24 Hours)

A licensed European doctor reviews your case, typically within 24 hours of submission. The doctor will either:

• Approve your prescription and recommend a specific medication and dose
• Request additional information before deciding (e.g., recent blood pressure readings)
• Recommend an alternative treatment more suitable for your profile
• Decline if contraindications are present, with an explanation of why

If declined, no payment is taken. The consultation is genuinely free — you only pay if your doctor approves treatment and you choose to proceed.

Step 5: Pharmacy Dispensing and Delivery

Once approved, our regulated EU pharmacy dispenses your medication in original manufacturer packaging. Cold-chain logistics maintain refrigeration during transit. Delivery times vary by country (as detailed above), but all medications arrive in plain, unbranded packaging that doesn’t reveal the contents.

Step 6: Ongoing Treatment Support

Through our secure patient portal, you can message your reviewing doctor anytime with questions about dosing, side effects, lifestyle changes, or progress. We provide nurse-led injection technique videos for first-time users and ongoing monitoring at major milestones (4 weeks, 12 weeks, 6 months).

What to Expect During Treatment

The First Four Weeks

All weight loss injections start at the lowest dose to allow your body to adapt. During the first 4 weeks at the starter dose, expect:

• Reduced appetite within 1–2 weeks
• Some nausea (most common side effect) for 1–2 weeks per dose increase
• Minor gastrointestinal symptoms (constipation or loose stools)
• Possible mild fatigue or headache
• Weight loss of 1–3% in the first month

Months 2–3

As you titrate to therapeutic doses, weight loss accelerates. Most patients have lost 5% of starting body weight by week 12. Side effects from titration typically decrease as your body adapts. Energy levels return to normal or improve. Many patients report changes in food preferences — high-fat and high-sugar foods become less appealing.

Months 4–6

This is typically the period of fastest weight loss. By week 20, most patients have lost approximately 10% of starting body weight. Body composition begins shifting noticeably. Clothing fits differently. Energy and physical capacity often improve substantially.

Months 6–18

Weight loss continues at a slower but steady pace. Most patients reach their maximum weight loss between months 12 and 18 (depending on the medication). For Mounjaro and Wegovy, average plateaus occur around 21–22% of starting body weight.

Beyond 18 Months — Long-Term Maintenance

Obesity is now widely recognised by medical authorities as a chronic disease requiring long-term treatment. Patients who continue treatment maintain their weight loss; those who stop typically regain approximately two-thirds of lost weight within 12 months. Your doctor will discuss long-term plans with you — most patients on these treatments continue indefinitely or step down to lower maintenance doses.

Side Effects and Safety in 2026

The safety profile of GLP-1 receptor agonists is now extremely well-characterised, with over 25 years of cumulative clinical experience across all indications. The most common side effects are gastrointestinal and manageable:

• Nausea — most common, affecting 25–44% during titration depending on medication
• Diarrhoea or constipation — typically transient
• Vomiting — less common, usually during dose increases
• Decreased appetite — intended therapeutic effect
• Fatigue and headache — usually mild
• Mild injection-site reactions — temporary redness or itching

Strategies to minimise side effects include eating smaller more frequent meals, staying well hydrated, avoiding fatty or rich foods (especially during titration), slowing dose escalation if needed, and rotating injection sites.

Serious side effects are rare but require immediate medical attention. Seek urgent care for severe abdominal pain (possible pancreatitis), persistent vomiting with inability to keep fluids down, signs of gallbladder disease (right upper quadrant pain, jaundice), vision changes, or signs of an allergic reaction (facial swelling, difficulty breathing).

Long-term safety data from the SUSTAIN, STEP, and SELECT trial programmes shows no increased risk of cancer, no neurological complications, and improved cardiovascular outcomes for patients with established heart disease.

Costs and Value: Understanding the Real Pricing of Weight Loss Injections

Online pricing for weight loss injections varies significantly across European pharmacies. EU Slim Store’s transparent all-inclusive pricing covers:

• The medication in original manufacturer packaging
• Free online consultation with a licensed European doctor
• Pharmacy dispensing from EU-regulated facility
• Ongoing patient support and follow-up
• Discreet temperature-controlled delivery

Beware extremely low-priced offers (significantly below the prices listed in our comparison table above). Genuine European GLP-1 medications cannot be sold below certain wholesale thresholds. Prices that seem too good to be true often indicate counterfeit products, expired stock, or unregulated sourcing from outside the EU regulatory framework.

Insurance Coverage in 2026

Coverage varies dramatically across European markets:

• Netherlands: Basisverzekering covers tirzepatide and semaglutide for confirmed type 2 diabetes; not for weight management alone.
• Germany: Coverage by GKV varies by Krankenkasse and case complexity. Some Krankenkassen reimburse for severe obesity with comorbidities.
• UK: NHS provides Wegovy and Mounjaro through specialist Tier 3 weight management services. Waiting lists are typically 12–18+ months.
• France: Limited reimbursement through Sécurité sociale; supplementary mutuelle coverage may apply for specific cases.
• Norway/Poland/Belgium: Generally private payment for weight management indications.

Most patients across all European markets pay privately for weight management treatment. The free consultation and transparent pricing model means there are no surprises.

Safety First: Recognizing Legitimate Online Pharmacies

The explosion in demand for weight loss injections has unfortunately attracted criminal counterfeit operations across Europe. Always verify that any online pharmacy meets these standards before purchasing:

• Licensed pharmacy registration — check official registers (GPhC for UK, IGJ for Netherlands, equivalents per country)
• Mandatory online consultation — any pharmacy selling GLP-1 medications without consultation is operating illegally
• Original manufacturer packaging — verify pen serial numbers and batch codes with the manufacturer if uncertain
• Cold-chain shipping — GLP-1 medications require refrigeration; pharmacies that ship without insulated packaging may have compromised stock
• Transparent regulatory information — legitimate pharmacies prominently display registration numbers, registered pharmacist details, and regulatory authorities

For a complete guide to spotting counterfeit operations, see our dedicated article on legitimate vs counterfeit weight loss injections.

Frequently Asked Questions

The FAQ section below covers the most common questions about buying weight loss injections in Europe. For product-specific questions, see the FAQ section on each individual product page.

Ready to Start Your Weight Loss Journey?

You’ve now read the most comprehensive 2026 guide to buying weight loss injections in Europe. You understand the seven major options, their relative effectiveness, country-by-country availability, eligibility criteria, the ordering process, and key safety considerations.

The next step is the consultation itself — and it’s genuinely free with no commitment.

Take the next step:

• Check your BMI to confirm eligibility
• Browse all weight loss injections to compare options
• Start your free online consultation — doctor response within 24 hours

For comparing Mounjaro and Wegovy specifically — by far the two most effective treatments — read our dedicated comparison: Mounjaro vs Wegovy: Which Should You Buy in 2026?

If you’d prefer non-injectable options, see our weight loss tablets range including Xenical, Mysimba, and Wegovy Pills.